News | Alzheimer's Prevention Registry

You are here

News

Come back regularly for the latest news and information about Alzheimer’s disease and prevention.

January 22, 2020
by Alzheimer's Prevention Bulletin
A woman in Colombia was destined to develop Alzheimer’s disease in her 40’s because of a rare family genetic mutation. But she didn’t show symptoms until her 70’s. Scientists are now investigating...
When biotechnology company Biogen announced the cancellation of the trial for their Alzheimer’s drug aducanumab, nearly 3,500 trial participants were left in limbo. Now, following the...
December 6, 2019
by Scientific American
Pharmaceutical giant Biogen now admits that it made a mistake back in March when it stopped a pair of trials of an experimental Alzheimer’s drug. A deep analysis of the data, released Thursday,...
If regulators approve it, the drug could become the first new medicine for Alzheimer's patients in nearly two decades.  
November 5, 2019
by GatesNotes
Get involved in a study to understand the disease.
In a decision likely to stir scientific debate across the world, China's health regulator conditionally approved a new Alzheimer's drug for patients with mild-to-moderate forms of the...
Researchers have found a woman with a rare genetic mutation that has protected her from dementia even though her brain has developed major neurological features of the disease.
I have spent my entire career interested in the mysteries of the brain: what it looks like, how it works and what happens when it doesn’t. Alzheimer’s disease has been the primary focus of my...
A UCLA-led study has found that MRI scans can help doctors distinguish whether a person's memory loss is being caused by Alzheimer's disease or by traumatic brain injury.
In an unexpected reversal, pharmaceutical giant Biogen said it will pursue US Food and Drug Administration approval for aducanumab, an experimental treatment for early Alzheimer's disease, ...